MedTrace Logo

Genetic & Environmental Determinants Of Immune Phenotype Variance: Establishing A Path Towards Personalized Medicine

NCT01699893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1012

Last updated 2015-05-29

No results posted yet for this study

Summary

The purpose of this study is to assess the determinants of immunologic variance within the general healthy population.

Conditions

  • Individuality

Interventions

OTHER

unique arm

blood, nasal swab, skin biopsy, stool samples

Sponsors & Collaborators

  • Institut Pasteur

    lead INDUSTRY

Principal Investigators

  • Matthew ALBERT · Institut Pasteur / Inserm

  • Lluis QUINTANA-MURCI · Institut Pasteur / CNRS

  • Nicolas FAUCHOUX · Biotrial Rennes

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01699893 on ClinicalTrials.gov